Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

4 Nov 2015 07:00

RNS Number : 4573E
Xaar PLC
04 November 2015
 



4 November 2015

 

Xaar plc

 

Scheduled Trading Statement

 

Xaar plc ("Xaar", "the Group" or "the Company"), the digital inkjet printing technology Group headquartered in Cambridge, UK, announces an update on trading.

 

Sales to date in the second half of 2015 have been broadly consistent with performance in the first six months of the year. The Board continues to expect 2015 full year revenue to be in the range of £92-95 million.

In ceramic tile printing, the Group's largest end application, monthly sales volumes have been fairly consistent but more recently we have seen some softening in demand in China, the largest market for ceramic tiles.

Sales into packaging in the second half of the year have been encouraging, supported by a strong presence at the Labelexpo show in September by our OEM label printer partners. We also launched the Xaar Print Bar System at the show, a new product which adds single-pass digital inkjet capability to existing analogue printing equipment. The launch has generated a significant amount of interest and we expect to be selling the first Print Bar units early next year. Direct-to-shape printing in packaging and industrial applications continues to gain momentum.

Next week Xaar will be exhibiting at InPrint 2015, the industrial printing show taking place in Munich on the 10-12 November. Xaar will be showing a range of products, including the Xaar 501 GS8 printhead and the Xaar Print Bar System. The Xaar 501 GS8 is designed for high-quality printing of large outdoor banners or indoor point-of-sale material, and is the first product to incorporate Xaar's PrecisionPlus architecture for uniform drop formation to enable exceptional print quality.

The Thin Film programme remains on track and OEM partner discussions continue.

The Group remains in a strong financial position with net cash at 31 October 2015 of £66.9 million (30 June 2015 - £58.6 million).

The Company expects to publish a full year trading update for the year ending 31 December 2015 on Wednesday 13th January 2016.

 

Contacts

 

Xaar plc

Alex Bevis, CFO

+44 (0)1223-423663

Doug Edwards, CEO

www.xaar.com

Tulchan Communications

James Macey White

+44 (0)20-7353-4200

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBIBDBRXGBGUX
Date   Source Headline
3rd Feb 20254:15 pmRNSTotal Voting Rights
22nd Jan 202512:30 pmRNSBlock listing Interim Review
21st Jan 20253:00 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading update & notification of full year results
15th Jan 20257:00 amRNSAppointment of Chief Financial Officer
11th Dec 202410:30 amRNS2024 Full Year Trading Update
4th Dec 202410:45 amRNSUpdate statement on 2024 AGM voting results
3rd Dec 202410:50 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSBoard changes
1st Nov 202412:00 pmRNSTotal Voting Rights
1st Oct 202411:30 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSInterim Results
2nd Sep 20241:45 pmRNSTotal Voting Rights
2nd Aug 20242:30 pmRNSHolding(s) in Company
1st Aug 202411:15 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSNOTICE OF RESULTS AND UPDATE ON TRADING
3rd Jul 202411:45 amRNSBlock listing Interim Review
2nd Jul 20242:00 pmRNSTotal Voting Rights
28th Jun 202410:00 amRNSDirector Declaration
3rd Jun 20242:45 pmRNSTotal Voting Rights
30th May 202412:00 pmRNSBoard changes
29th May 20241:45 pmRNSResult of AGM
29th May 20249:30 amRNSHolding(s) in Company
21st May 20249:30 amRNSDirector/PDMR Shareholding
20th May 20244:30 pmRNSDirector/PDMR Shareholding
13th May 20249:42 amRNSHolding(s) in Company
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.